Taysha Gene Therapies Inc

The current institutional shareholding score of Taysha Gene Therapies Inc is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 100.06%, representing a quarter-over-quarter increase of 1.93%. The largest institutional shareholder is Steven Cohen, holding a total of 358.26K shares, representing 0.16% of shares outstanding, with 0.44% decrease in holdings.